Dr. Enzler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8902Fax+1 734-936-4940
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2013 - 2015
University Medicine GoettingenClinical Fellowship, Hematology and Oncology, 2010 - 2013- Harvard Medical School/ Free University BerlinPhD, Immunology, Magna cum Laude, 2000 - 2004
University of Basel Faculty of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2015 - 2025
MI State Medical License 2018 - 2025
NY State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Medical Board Lower Saxony GermanyHematology and Oncology
Awards, Honors, & Recognition
- FACP ACP, 2021
Clinical Trials
- NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma Start of enrollment: 2021 Jan 21
Roles: Contact
Publications & Presentations
PubMed
- BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer.Vaibhav Sahai, Kent A Griffith, Bruce S Lin, Heloisa P Soares, Sreenivasa R Chandana
Med. 2024-12-18 - 1 citationsA Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.Thomas Enzler, Jiaqi Shi, Jake McGue, Brian D Griffith, Lei Sun
International Journal of Molecular Sciences. 2024-03-03 - 9 citationsDevimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).Arathi Mohan, Kent A Griffith, Fulei Wuchu, David B Zhen, Chandan Kumar-Sinha
Clinical Cancer Research. 2023-07-05
Professional Memberships
- Member
- Member
- European Society for Medical Oncology - ESMOMember
- German Society of Hematology and Oncology - DGHOMember
- Member
- Member
Other Languages
- German, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
